Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial.

被引：0
|
作者：
Saliba, F. [1 ]
Brown, R. S., Jr. [1 ]
Metselaar, H. [1 ]
Beckebaum, S. [1 ]
Duvoux, C. [1 ]
Navasa, M. [1 ]
Dong, G. [2 ]
Lopez, P. [3 ]
Nevens, F. [1 ]
机构：
[1] H2304 Study Grp, Villejuif, France
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [31] Effect of Everolimus on Left Ventricular Hypertrophy of De Novo Kidney Transplant Recipients: A 1 Year, Randomized, Controlled Trial
    Paoletti, Ernesto
    Marsano, Luigina
    Bellino, Diego
    Cassottana, Paolo
    Cannella, Giuseppe
    TRANSPLANTATION, 2012, 93 (05) : 503 - 508
  • [32] Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study.
    Saito, K.
    Uchida, K.
    Takahara, S.
    Yoshimura, N.
    Teraoka, S.
    Cornu-Artis, C.
    Kobayashi, E.
    Takahashi, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 314 - 314
  • [33] Impact on Wound Healing Events After Early Conversion to Everolimus in De Novo Renal Transplant Recipients: 24-Month Results from the Randomized ELEVATE Study.
    Nashan, B.
    van der Giet, M.
    Holdaas, H.
    Zeier, M.
    Pascual, J.
    Avihingsanon, Y.
    Lopez, P.
    Aguilar-Sanchez, J.
    Kochuparampil, J.
    Wang, Z.
    Cruzado, J.
    De Fijter, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 534 - 534
  • [34] Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial
    Andreassen, Arne K.
    Broch, Kaspar
    Eiskjaer, Hans
    Karason, Kristjan
    Gude, Einar
    Molbak, Dorte
    Stueflotten, Wenche
    Gullestad, Lars
    TRANSPLANTATION, 2019, 103 (04) : 781 - 788
  • [35] EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL
    De Simone, P.
    Fischer, L.
    Kaiser, G.
    Jonas, S.
    Heise, M.
    Schemmer, P.
    Pascher, A.
    Schlitt, H.
    Paulus, E.
    Mertens, M.
    Duvoux, C.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 3 - 3
  • [36] ASSESSMENT OF PROTEINURIA REPORTED AS ADVERSE EVENTS IN DE NOVO RENAL TRANSPLANT RECIPIENTS RECEIVING AN EVEROLIMUS-BASED REGIMEN: 24-MONTH RESULTS FROM TRANSFORM
    Legendre, C.
    Buchler, M.
    Pernin, V.
    Berger, S. P.
    Oppenheimer, F.
    Wiseman, A.
    Viklicky, O.
    Russ, G. R.
    Danguilan, R.
    Basic-Jukic, N.
    Mor, E.
    Narvekar, P.
    Hernandez-Gutierrez, M. P.
    Bernhardt, P.
    Gharbi, H.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 5 - 5
  • [37] Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis
    Singh, N
    Zeevi, A
    Gayowski, T
    Marino, IR
    TRANSPLANT INTERNATIONAL, 1998, 11 (04) : 308 - 311
  • [38] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
  • [39] DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS: CORRELATION BETWEEN LIPID LEVELS AND CARDIOVASCULAR EVENTS BASED ON THE 24 MONTH RESULTS OF A2310 STUDY
    Potena, Luciano
    Bara, Christoph
    Dong, Gaohong
    Lopez, Patricia
    Epailly, Eric
    TRANSPLANT INTERNATIONAL, 2015, 28 : 436 - 436
  • [40] Assessment of Proteinuria Reported as Adverse Events in De Novo Renal Transplant Recipients Receiving an Everolimus-Based Regimen: 24-Month Results from TRANSFORM.
    Legendre, C.
    Berger, S.
    Oppenheimer, F.
    Wiseman, A.
    Steinberg, S.
    Viklicky, O.
    Russ, G.
    Danguilan, R.
    Basic-Jukic, N.
    Mor, E.
    Narvekar, P.
    Gutierrez, M. P. Hernandez
    Bernhardt, P.
    Sommerer, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 693 - 694
12345